Patents by Inventor Jacques Theze

Jacques Theze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC METHODS AND COMPOSITIONS
    Publication number: 20230038788
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Application
    Filed: June 14, 2022
    Publication date: February 9, 2023
    Inventors: JACQUES THEZE, THIERRY ROSE, FLORENCE BUGAULT
  • ANTIBODIES AND THE USES THEREOF
    Publication number: 20220281959
    Abstract: The present invention relates to antibodies and their use. The invention particularly relates to antibodies against a particular domain of gp41, pharmaceutical compositions or kits or any device comprising the same, as well as the uses thereof. The invention is particularly useful for treating (e.g., curing or preventing), detecting or monitoring AIDS in a subject, either, alone or in combination with other treatments/agents.
    Type: Application
    Filed: August 26, 2020
    Publication date: September 8, 2022
    Inventors: JULIEN POTHLICHET, JACQUES THEZE
  • Therapeutic methods and compositions
    Patent number: 11365264
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: June 21, 2022
    Assignee: INSTITUT PASTEUR
    Inventors: Jacques Theze, Thierry Rose, Florence Bugault
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20220127377
    Abstract: The present invention relates to compositions and methods for treating cancers in a subject in need thereof. The invention more particularly relates to methods of treating cancers by inhibiting PLA2-GIB in a subject in need thereof.
    Type: Application
    Filed: February 5, 2020
    Publication date: April 28, 2022
    Inventors: JACQUES THEZE, BLANCHE TAMARIT, PHILIPPE POULETTY
  • Use of peptides to stimulate the immune system
    Patent number: 11154587
    Abstract: Methods for treating immunodeficiencies are provided using peptide-based compounds.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: October 26, 2021
    Assignee: DIACCURATE
    Inventors: Blanche Tamarit, Jacques Theze
  • ANTI-PLA2-GIB ANTIBODIES AND THE USES THEREOF
    Publication number: 20210047431
    Abstract: The present invention relates to anti-PLA2-GIB antibodies and the uses thereof, particularly for detecting human PLA2-GIB in a sample.
    Type: Application
    Filed: March 4, 2019
    Publication date: February 18, 2021
    Inventors: BLANCHE TAMARIT, JACQUES THEZE
  • THERAPEUTIC ANTI-SPLA2-GIB ANTIBODIES AND THE USES THEREOF
    Publication number: 20210047432
    Abstract: The present invention relates to human or humanized antibodies which bind PLA2-GIB, their production and the uses thereof. These antibodies exhibit advantageous characteristics, in particular for therapeutic and diagnostic purposes.
    Type: Application
    Filed: March 4, 2019
    Publication date: February 18, 2021
    Inventors: BLANCHE TAMARIT, JACQUES THEZE
  • Use of indole compounds to stimulate the immune system
    Patent number: 10894035
    Abstract: Methods for treating immunodeficiencies are provided using indole-based compounds.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: January 19, 2021
    Assignee: DIACCURATE
    Inventors: Jacques Theze, Blanche Tamarit
  • INHIBITORS OF PLA2-G1B COFACTORS FOR TREATING CANCER
    Publication number: 20200399392
    Abstract: The present invention relates to novel therapeutic approaches for treating cancer in mammals, particularly in human subjects, using an inhibitor of a PLA2-GIB cofactor.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: JULIEN POTHLICHET, PHILIPPE POULETTY, JACQUES THEZE
  • MODULATION OF PLA2-G1B IN THERAPY
    Publication number: 20200397855
    Abstract: The present invention relates to novel therapeutic approaches for treating or preventing diseases in mammals, particularly in human subjects, using a PLA2-GIB cofactor, or a modulator of a PLA2-GIB cofactor.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Inventors: JULIEN POTHLICHET, PHILIPPE POULETTY, JACQUES THEZE
  • USE OF INDOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM
    Publication number: 20180344694
    Abstract: Methods for treating immunodeficiencies are provided using indole-based compounds.
    Type: Application
    Filed: August 30, 2016
    Publication date: December 6, 2018
    Inventors: JACQUES THEZE, BLANCHE TAMARIT
  • USE OF PEPTIDES TO STIMULATE THE IMMUNE SYSTEM
    Publication number: 20180296632
    Abstract: Methods for treating immunodeficiencies are provided using peptide-based compounds.
    Type: Application
    Filed: October 7, 2016
    Publication date: October 18, 2018
    Applicant: DIACCURATE
    Inventors: BLANCHE TAMARIT, JACQUES THEZE
  • THERAPEUTIC METHODS AND COMPOSITIONS
    Publication number: 20160311926
    Abstract: Methods for diagnosing or treating immune disorders in a subject are provided. The methods are based on the detection or modulation of Refractory state Inducing Factor (RIF).
    Type: Application
    Filed: December 22, 2014
    Publication date: October 27, 2016
    Inventors: JACQUES THEZE, THIERRY ROSE, FLORENCE BUGAULT
  • PEPTIDES OF IL-2
    Publication number: 20100273723
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: January 21, 2010
    Publication date: October 28, 2010
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
    Patent number: 7704490
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: April 27, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
    Patent number: 7662368
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: February 16, 2010
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Publication number: 20070048302
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: July 28, 2006
    Publication date: March 1, 2007
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2
    Patent number: 7101965
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 5, 2006
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20060018873
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: June 28, 2005
    Publication date: January 26, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof
    Patent number: 6929791
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: August 16, 2005
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie